These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 34481949)

  • 1. A Proteomic Study on the Membrane Protein Fraction of T Cells Confirms High Substrate Selectivity for the ER Translocation Inhibitor Cyclotriazadisulfonamide.
    Pauwels E; Rutz C; Provinciael B; Stroobants J; Schols D; Hartmann E; Krause E; Stephanowitz H; Schülein R; Vermeire K
    Mol Cell Proteomics; 2021; 20():100144. PubMed ID: 34481949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced DNAJC3 Expression Affects Protein Translocation across the ER Membrane and Attenuates the Down-Modulating Effect of the Translocation Inhibitor Cyclotriazadisulfonamide.
    Pauwels E; Provinciael B; Camps A; Hartmann E; Vermeire K
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Proteomic Survey Indicates Sortilin as a Secondary Substrate of the ER Translocation Inhibitor Cyclotriazadisulfonamide (CADA).
    Van Puyenbroeck V; Claeys E; Schols D; Bell TW; Vermeire K
    Mol Cell Proteomics; 2017 Feb; 16(2):157-167. PubMed ID: 27998951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preprotein signature for full susceptibility to the co-translational translocation inhibitor cyclotriazadisulfonamide.
    Van Puyenbroeck V; Pauwels E; Provinciael B; Bell TW; Schols D; Kalies KU; Hartmann E; Vermeire K
    Traffic; 2020 Feb; 21(2):250-264. PubMed ID: 31675144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small Molecule Cyclotriazadisulfonamide Abrogates the Upregulation of the Human Receptors CD4 and 4-1BB and Suppresses In Vitro Activation and Proliferation of T Lymphocytes.
    Claeys E; Pauwels E; Humblet-Baron S; Provinciael B; Schols D; Waer M; Sprangers B; Vermeire K
    Front Immunol; 2021; 12():650731. PubMed ID: 33968048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signal peptide-binding drug as a selective inhibitor of co-translational protein translocation.
    Vermeire K; Bell TW; Van Puyenbroeck V; Giraut A; Noppen S; Liekens S; Schols D; Hartmann E; Kalies KU; Marsh M
    PLoS Biol; 2014 Dec; 12(12):e1002011. PubMed ID: 25460167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The signal peptide as a new target for drug design.
    Lumangtad LA; Bell TW
    Bioorg Med Chem Lett; 2020 May; 30(10):127115. PubMed ID: 32209293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stable isotope labeling by amino acids in cell culture and differential plasma membrane proteome quantitation identify new substrates for the MARCH9 transmembrane E3 ligase.
    Hör S; Ziv T; Admon A; Lehner PJ
    Mol Cell Proteomics; 2009 Aug; 8(8):1959-71. PubMed ID: 19457934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuning Side Arm Electronics in Unsymmetrical Cyclotriazadisulfonamide (CADA) Endoplasmic Reticulum (ER) Translocation Inhibitors to Improve their Human Cluster of Differentiation 4 (CD4) Receptor Down-Modulating Potencies.
    Chawla R; Van Puyenbroeck V; Pflug NC; Sama A; Ali R; Schols D; Vermeire K; Bell TW
    J Med Chem; 2016 Mar; 59(6):2633-47. PubMed ID: 26974263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CADA inhibits human immunodeficiency virus and human herpesvirus 7 replication by down-modulation of the cellular CD4 receptor.
    Vermeire K; Zhang Y; Princen K; Hatse S; Samala MF; Dey K; Choi HJ; Ahn Y; Sodoma A; Snoeck R; Andrei G; De Clercq E; Bell TW; Schols D
    Virology; 2002 Oct; 302(2):342-53. PubMed ID: 12441078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CADA, a potential anti-HIV microbicide that specifically targets the cellular CD4 receptor.
    Vermeire K; Brouwers J; Van Herrewege Y; Le Grand R; Vanham G; Augustijns P; Bell TW; Schols D
    Curr HIV Res; 2008 May; 6(3):246-56. PubMed ID: 18473788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A potent oligosaccharyl transferase inhibitor that crosses the intracellular endoplasmic reticulum membrane.
    Eason PD; Imperiali B
    Biochemistry; 1999 Apr; 38(17):5430-7. PubMed ID: 10220330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of signal peptide features for substrate specificity in human Sec62/Sec63-dependent ER protein import.
    Schorr S; Nguyen D; Haßdenteufel S; Nagaraj N; Cavalié A; Greiner M; Weissgerber P; Loi M; Paton AW; Paton JC; Molinari M; Förster F; Dudek J; Lang S; Helms V; Zimmermann R
    FEBS J; 2020 Nov; 287(21):4612-4640. PubMed ID: 32133789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and cellular kinetics of dansyl-labeled CADA derivatives with anti-HIV and CD4 receptor down-modulating activity.
    Vermeire K; Lisco A; Grivel JC; Scarbrough E; Dey K; Duffy N; Margolis L; Bell TW; Schols D
    Biochem Pharmacol; 2007 Aug; 74(4):566-78. PubMed ID: 17603023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane.
    Hannigan MM; Hoffman AM; Thompson JW; Zheng T; Nicchitta CV
    Mol Cell Proteomics; 2020 Nov; 19(11):1826-1849. PubMed ID: 32788342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibition of cotranslational translocation of vascular cell adhesion molecule 1.
    Besemer J; Harant H; Wang S; Oberhauser B; Marquardt K; Foster CA; Schreiner EP; de Vries JE; Dascher-Nadel C; Lindley IJ
    Nature; 2005 Jul; 436(7048):290-3. PubMed ID: 16015337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative proteomic analyses of human cytomegalovirus-induced restructuring of endoplasmic reticulum-mitochondrial contacts at late times of infection.
    Zhang A; Williamson CD; Wong DS; Bullough MD; Brown KJ; Hathout Y; Colberg-Poley AM
    Mol Cell Proteomics; 2011 Oct; 10(10):M111.009936. PubMed ID: 21742798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus type 1 escape from cyclotriazadisulfonamide-induced CD4-targeted entry inhibition is associated with increased neutralizing antibody susceptibility.
    Vermeire K; Van Laethem K; Janssens W; Bell TW; Schols D
    J Virol; 2009 Sep; 83(18):9577-83. PubMed ID: 19570853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of Progranulin-Induced Breast Cancer Stem Cell Propagation by Sortilin-Targeting Cyclotriazadisulfonamide (CADA) Compounds.
    Berger K; Pauwels E; Parkinson G; Landberg G; Le T; Demillo VG; Lumangtad LA; Jones DE; Islam MA; Olsen R; Kapri T; Intasiri A; Vermeire K; Rhost S; Bell TW
    J Med Chem; 2021 Sep; 64(17):12865-12876. PubMed ID: 34428050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative Proteomics and Differential Protein Abundance Analysis after the Depletion of PEX3 from Human Cells Identifies Additional Aspects of Protein Targeting to the ER.
    Zimmermann R; Lang S; Lerner M; Förster F; Nguyen D; Helms V; Schrul B
    Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.